the current role of plasmapheresis in the treatment landscape for ttp
Published 4 weeks ago • 56 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
1:05
tpe animation
-
9:25
mgus diagnosis: a step-by-step approach
-
1:54
the science behind tapinarof, an aryl hydrocarbon receptor agonist
-
0:45
difference between quality of life & patient-reported outcomes
-
2:41
advances in the treatment and prognosis of ttp
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:23
t-cell metabolism: a novel therapeutic avenue for gvhd
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:19
the potential of caplacizumab in the treatment of attp
-
1:10
upcoming novel agents for the treatment of sickle cell disease
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
3:33
the growing role of machine learning in hematological oncology
-
0:52
tocilizumab for aa amyloidosis
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
10:42
a detailed overview of the current and emerging gene therapies for hemophilia a & b